On Monday, Shares of Ford Motor Co. (NYSE:F), gained 1.11% to $14.55.
Ford Motor Company will release its July 2015 U.S. sales results at about 9:15 a.m. ET Monday, August 3, 2015. At 10:00 a.m. ET, Erich Merkle, Ford U.S. sales analyst, will host a conference call for the investment community and news media to talk about the results and related market trends. He will be joined by Mark LaNeve, Ford vice president, U.S. Marketing, Sales and Service, and Yong Yang, Ford’s senior U.S. economist.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories.
Shares of Hewlett-Packard Company (NYSE:HPQ), declined -1.82% to $30.25, during its last trading session.
As part of ongoing efforts to lower the carbon footprint of its business, Hewlett-Packard Company declared that it has signed a 12-year power purchase agreement (PPA) for 112 megawatts (MW) of wind power with SunEdison, Inc. (NYSE: SUNE), the world’s largest renewable energy development company.
The 112 MW of locally generated wind electricity is sufficient to power 100 percent of HP’s Texas-based data center operations, the equivalent of powering 42,600 homes each year, and will avoid the emission of more than 340,000 tons of carbon dioxide annually.
The agreement will allow HP to reach its 2020 operational greenhouse gas (GHG) emissions reduction aim by the end of FY15, five years ahead of plan. That aim originally aimed to reduce total GHG emissions from its operations (Scope 1 and Scope 2) by 20 percent of 2010 levels by 2020.
The about 1.5 million square feet of Texas data center operations support HP’s entire internal global information technology (IT) requirements and the delivery of IT services to a portion of HP customers. HP presently operates five data centers in Texas, located in Houston, Hockley, Plano, and two in Austin.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to to the government, health, and education sectors worldwide.
Finally, Eli Lilly and Company (NYSE:LLY), ended its last trade with -0.67% loss, and closed at $84.15.
Eli Lilly and Company has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the Phase 3 trial of the investigational medicine evacetrapib, based on data from an interim futility analysis.
Last patient visit in ACCELERATE – which is evaluating evacetrapib in about 12,000 patients with high-risk atherosclerotic cardiovascular disease (ASCVD) – is predictable in July 2016.
“We believe that evacetrapib, if approved, could offer a noteworthy benefit in the treatment of high-risk cardiovascular disease,” said David Ricks, Lilly senior vice president and president of Lilly Bio-Medicines. “While happy that the trial continues, we need to complete the ACCELERATE study to understand the potential for evacetrapib. The interim futility test was designed to assess whether the drug had any possibility of achieving its primary endpoints. We look forward to receiving the ACCELERATE results in 2016.”
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.